The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
April 28th 2025
From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ground.
Dr Shoaib Ugradar Discusses Teprotumumab for Thyroid Eye Disease and Data Collected
March 21st 2022Teprotumumab has shown great efficacy in treating thyroid eye disease in both clinical trials and real-world settings, but more data are needed on adverse events, said Shoaib Ugradar, MD, UCLA Stein Eye Center Santa Monica.
Watch
Examining Adjuvant Therapies in PD When Levodopa Wanes
March 19th 2022A randomized clinical trial examined patient quality of life in Parkinson disease (PD) when adding different adjuvant therapies to levodopa to help control dyskinesia and a flaring of symptoms during OFF periods to see if one drug class had any benefit over another.
Read More
Increasing Rates of Women Receive Testing for Obstructive Sleep Apnea Diagnosis, According to Study
March 19th 2022A recent study found that older men with higher body mass index are more likely to receive a diagnosis of obstructive sleep apnea, but women are accounting for a growing number of new diagnoses.
Read More
Current Strategies and the Potential of CAR T-Cell Therapy in Relapsed and Refractory MCL
March 19th 2022Mantle cell lymphoma is a difficult cancer type with high relapse rates, but novel targeted approaches such as CAR T-cell therapy hold promise for more successful response rates in the future.
Read More
Dupilumab Meaningfully Reduces Symptoms for Patients With EoE, Study Finds
March 19th 2022Compared with placebo, dupilumab treatment resulted in statistically significant and meaningful symptom improvements in adults and adolescents with eosinophilic esophagitis (EoE), according to abstracts presenting findings from the 3-part LIBERTY-EoE-TREET study.
Read More
FDA Approves FoundationOne CDx to Identify EGFR Therapeutics for Certain Patients With NSCLC
March 19th 2022FoundationOne CDx has been approved as a companion diagnostic to identify patients with non–small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 alternations eligible for treatment with EGFR tyrosine kinase inhibitors.
Read More
MM and Regimens for First- and Second-Line Treatment
March 15th 2022Joshua Richter, MD, and Roy Beveridge, MD, explain the role triplet regimens play in MM treatment and how physician decision-making has been impacted since the NCCN guidelines have expanded the list of acceptable first- and second-line treatment options.
Watch
Health Care Fragmentation and Blood Pressure Control Among Adults Taking Antihypertensive Medication
Among older Black adults taking antihypertensive medication, fragmented ambulatory health care was associated with an increased likelihood of apparent treatment-resistant hypertension with uncontrolled blood pressure.
Read More
Potential Link Found Between Thrombotic Events, Mortality in Patients With PV, ET
March 13th 2022Patients with polycythemia vera (PV) or essential thrombocythemia (ET) had a higher risk of thrombotic events than the general population, which was associated with mortality in a recent study.
Read More
Elevated Repolarization Dispersion Linked With LV Diastolic Discoordination in Pediatric PAH
March 12th 2022Repolarization dispersion has been linked to echocardiographic measures of diastolic dysfunction in past research, and a recent study found it potentially indicative of pulmonary arterial hypertension severity.
Read More
Study Finds Better Outcomes When Patients Admitted With ARF Have Quick Inter-ICU Transfers
March 11th 2022A retrospective, quasi-experimental study found that patients admitted to the intensive care unit (ICU) for acute respiratory failure (ARF) saw better outcomes when an inter-ICU transfer came within the first 2 days of admittance.
Read More
Addressing Low Vitamin D Levels May Reduce Risk of Peripheral Neuropathy in MM
March 11th 2022Researchers found that low levels of vitamin D and the prevalence of peripheral neuropathy were common in patients with multiple myeloma, suggesting that addressing the former could help prevent the latter.
Read More